登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《重新评估作为食品添加剂的海藻酸及其钠、钾、铵和钙盐（E 400-E 404）》

  • 来源专题：食物与营养
  • 编译者： lixiaoman
  • 发布时间：2017-11-30

  • 本发明涉及用作食品添加剂的海藻酸及其钠盐、钾盐、铵盐和钙盐（E 400-E 404）的重新评估。根据法规（EC）No 1333/2008的附录II和附录III，海藻酸及其盐（E 400-E 404）在欧盟获得食品添加剂的授权。根据委员会法规（EU）No 257/2010重新评估的某些食品添加剂的风险评估的概念框架之后，小组得出结论认为没有必要用海藻酸及其盐，并且在报告中解释了海藻酸及其盐作为食品添加剂的使用方面。

159浏览量
原文链接
相关报告

  • 《瓜尔胶作为食品添加剂(412 E)的重新评估》
    • 来源专题：食物与营养
    • 编译者：huangzheng
    • 发布时间：2017-03-26
    • 添加到食品食品添加剂和营养来源(ANS)提供了一个科学的观点重新评估安全的瓜尔胶作为食品添加剂(412 E)。在欧盟,瓜尔胶评估了粮农组织/世卫组织食品添加剂专家委员会(联合)在1970年,1974年和1975年,分配一个可接受的每日摄入量(ADI)未指定的。瓜尔胶也评估了食品科学委员会(SCF)在1977年批准了ADI的未指定分配的联合。后国际患者安全分类的概念性框架下的某些食品添加剂重新评估风险评估委员会监管(欧盟)没有257/2010,专家组认为足够的曝光和毒性数据可用为止。瓜尔胶是几乎未消化的,而不是吸收完整,但在人类明显由肠道细菌发酵。没有不良反应报告subchronic和致癌性研究最高剂量测试;没有对基因毒性的关注。口服摄入的瓜尔胶在成人耐受性良好。专家组得出结论,没有必要为一个数值ADI瓜尔胶(E 412),和没有安全关心大众精制暴露评估的瓜尔胶作为食品添加剂(412 E)。专家组认为,瓜尔胶使用的食物用于婴幼儿腹部不适的发生应该监控和如果这种效应是观察到剂量应该被识别为基础进一步风险评估。专家组认为没有足够的具体研究解决的安全使用瓜尔胶(412 E)在食品类别13.1.5.1和13.1.5.2都是可用的。因此,委员会得出结论,可用的数据不允许足够的瓜尔胶的安全评估(412 E)在婴幼儿食用这些食物特殊医疗用途。
    327浏览量
    原文链接

  • 《对抗坏血酸（E 315）和异抗坏血酸钠（E 316）作为食品添加剂的重新评估的科学意见》
    • 来源专题：食物与营养
    • 编译者：潘淑春
    • 发布时间：2016-05-25
    • The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientific opinion re-evaluating the safety of erythorbic acid (E 315) and sodium erythorbate (E 316) as food additives. The use of these food additives was evaluated by the Scientific Committee on Food (SCF) that established an acceptable daily intake (ADI) of 6 mg/kg body weight (bw)/day. Intestinal absorption of erythorbate was reported from a mice study and near complete excretion within 24 h from a guinea pig study. The Panel noted that the acute toxicity of erythorbic acid or sodium erythorbate is low, there was no indication of adverse effects from the available subchronic toxicity studies, there is no concern with respect to their genotoxicity neither to respect to carcinogenicity. The Panel identified a no observed adverse effect level (NOAEL) of 650 mg/kg bw/day based on a decrease in body weight from a carcinogenicity study. No maternal and developmental effects were observed from a prenatal developmental toxicity study with sodium erythorbate. The Panel recognised the limitation of the overall toxicological database (no reproductive and chronic toxicity studies), but did not consider necessary to increase the usual uncertainty factor of 100 in deriving an ADI. Therefore, the Panel concluded that there is no reason to revise the current ADI of 6 mg/kg bw/day. Combined dietary exposure to erythorbic acid and sodium erythorbate from their use as food additives was calculated. Considering that the ADI is not exceeded by any population group, the Panel also concluded that the use of erythorbic acid (E 315) and sodium erythorbate (E 316) as food additives at the permitted or reported use and use levels would not be of safety concern.
    329浏览量
    原文链接